Proteinases participate in a large variety of cell processes, namely, in modeling and communication, but their activity could be detrimental if not tightly controlled. The activity of many proteinases is controlled by the occurrence of endogenous protein inhibitors as is the case for matrix metalloproteinases with which such inhibitors may form hardly reversible complexes (1). For other proteinases, the control mechanism is the necessary cleavage of a segment of a propeptide to release the mature proteinase, endowed with catalytic activity, a scheme that applies, for instance, to the pancreatic carboxypeptidases (2-4).
These two major control mechanisms are not mutually exclusive but, for carboxypeptidases A and B (CPA and CPB, respectively) , the only known protein inhibitors-i.e., the inhibitors from Solanacea (5, 6) or Ascaris lumbricoides (7)-are not of mammalian origin.
We have recently characterized in brain and several other extrapancreatic tissues the presence of CPA1 and CPA2 gene transcripts that were not accompanied, however, by any typical CPA catalytic activity, even using extremely sensitive detection systems (8). For CPA2, this discrepancy was explained by the fact that the transcript corresponds to a splice variant leading to a shorter CPA2 isoform with modified CPA activity. In contrast, for CPA1, a mRNA encoding the full-size pancreatic
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propeptide was characterized but no CPA activity could be generated after incubation of tissue extracts in presence of trypsin under conditions that should have severed the "activation segment" and released the mature CPA. The discrepancy was explained, in this case, by detection, in extracts from brain and other tissues expressing the CPA1 gene, of an endogenous inhibitory activity directed toward added bovine pancreatic CPA. The latter was rather thermostable but sensitive to the action of Pronase.
In the present work, we have purified this tissue carboxypeptidase inhibitor (TCI) from rat brain, cloned the corresponding cDNA,t and studied its properties and tissue distribution.
MATERIALS AND METHODS Materials. CPA (from bovine pancreas, 50 units/mg of protein), CPB (from porcine pancreas, 105 units/mg of protein), carboxypeptidase Y (CPY, from baker's yeast, 100 units/mg of protein), leucine aminopeptidase (from porcine pancreas, 140 units/mg of protein), phenylmethylsulfonyl fluoride, o-phthaldialdehyde, hippuryl-L-phenylalanine (HF), Nethylmaleimide, and leupeptin were supplied by Sigma; aminopeptidase M (from hog kidney, 20 units/mg of protein) was from Pierce; a-chymotrypsin (from porcine pancreas, 20 units/mg of protein), trypsin (from bovine pancreas, 10,900 units/mg of protein), and elastase (from porcine pancreas, 85 units/mg of protein) were from Boehringer Mannheim; and Ala-AMC and other AMC substrates were from Bachem (AMC is 7-amido-4-methylcoumarin).
Radioactive materials were from Amersham and other materials were from commercial sources.
Enzyme Activity Determinations. CPA activity was determined by using the radioiodinated Bolton-Hunter reagent derivative of the dipeptide Arg-Phe as substrate (8). Briefly, samples (50 ,ul) were incubated with radioiodinated BoltonHunter reagent-coupled Arg-Phe (105 dpm, 50 1,l), the reaction was stopped by adding 0.2 M HCl (50 ,ul), and liberated 125I-labeled Bolton-Hunter reagent was recovered by reversephase chromatography (Porapak Q, Millipore (40 units) . This template was amplified in 0.1 ml of a reaction mixture containing the degenerated sense primer (mixture of 48 different 20-mers, 0.4 ,uM), 1.5 mM MgCl2, 50 mM KCl, 0.01% gelatin, and 1 unit of Taq polymerase, for 35 cycles, the annealing step being at 46°C. The reaction products were resolved by gel electrophoresis (2% NuSieve agarose and 1% agarose), and the band of interest was extracted. The DNA was purified by using a Geneclean II kit, blunt-ended with T4 DNA polymerase, phosphorylated, and subcloned in a Sma I-digested pGEM-4Z.
A probe generated by reverse transcription-coupled PCR (RT-PCR) from rat brain poly(A)+ mRNA by using degenerated primers designed from peptide 2 (see Fig. 3 ) was used to screen a rat hypothalamic cDNA library (1 X 106 phages) constructed on AZAP II (Stratagene). This probe (1 X 106 dpm/ml) was hybridized in 40% (vol/vol) formamide/4X SSC/lx Denhardt's solution/8 mM Tris-HCl, pH 7.4/yeast tRNA (20 ,ug/ml)/0.1% SDS/salmon sperm DNA (20 ,ug/ ml)/10% (wt/vol) dextran sulfate. Clones were plaquepurified and Bluescript KS(+) plasmids containing cDNA inserts were recovered using the helper phage R508 and sequenced (15). The sequence of 3'-end region was completed by using a rapid amplification of cDNA ends system (16 Proc. Natl. Acad. Sci. USA 92 (1995) Cell Biology: Normant et al. (Fig. 2) . TCI, isolated by excision, was blotted onto a nylon membrane and digested by endoproteinase Lys-C. Among the 30 peptides generated, three were sequenced, one of them containing 34 amino acids (peptide 2 in Fig. 3 ).
Cloning of a cDNA Corresponding to TCI. Two partially degenerate oligonucleotides were designed from peptide 2 to perform RT-PCR: the sense primer was a mixture of 48 20-base oligonucleotides, corresponding to the peptide MGQGSAP, and the antisense primer, a mixture of 32 20-mers, corresponding to the peptide FYQRLMS (Fig. 3) (Fig. 3) . The 646-bp 3' end of another clone (A18, 1200 bp) was homologous to that of A13, but the upstream sequence diverged from it at position 152. The divergent sequence around position 152 (CCAAAAG/ CCACCC) displayed a potential intron-exon structure (18 lation signal and the poly(A) tail was 16 bp, corresponding to the consensus distance between these sites. Properties of Recombinant TCI. After the transformation of an E. coli strain with a 890-bp cDNA encoding TCI, the protein was obtained in nearly pure form by combination of (NH4)2-SO4 precipitation and chromatofocusing. The recombinant TCI exhibited, like TCI purified from rat brain, an apparent molecular mass of 30 kDa and was recognized on Western blots by antibodies raised against the latter (Fig. 2) .
The purified recombinant TCI inhibited bovine CPA with an IC50 value of 2 nM (data not shown) and in an apparently noncompetitive manner (Fig. 4A) . To determine whether TCI exhibited a reversible effect on the enzyme, purified bovine CPA was incubated for 1 h with recombinant TCI (100 nM, i.e., 30-fold the apparent Kj), and an excess of substrate (30 mM, HF) was added. TCI afforded complete inhibition, whereas 2-benzyl-3-mercaptopropanoic acid [2 ,uM, i.e., 200-fold the Ki Rat CPA2 (short isoform), mouse CPH, human CPM, porcine aminopeptidase M, porcine leucine aminopeptidase, human neprilysin, human peptidyl dipeptide hydrolase, human leukotriene A4 hydrolase, yeast CPY, bovine trypsin, porcine a-chymotrypsin, and porcine elastase tested under the same experimental procedures were not inhibited (i.e., IC50 > 1 ,uM). Poly(A)+ mRNAs (8 jig per lane) were used. The blot was hybridized with a 102-bp 32P-labeled probe (3.5 x 106 dpm/ml), corresponding to peptide 2 cDNA (Fig. 3) , and exposed for 7 days at -80°C with intensifying screens. Molecular sizes (kb) are indicated.
(19)], a reversible inhibitor, did not (Fig. 4B ). CPA1 and CPA2 from rat pancreas were inhibited with similar potencies, whereas inhibition of other carboxypeptidases was less potent and other metallopeptidases or serine proteases were not significantly inhibited ( When severed from the proenzyme, the two activation segments of CPA and CPB differ, however, in that the former is still a selective and potent inhibitor (Ki = 2 nM) of CPA whereas the latter is inactive (3, 4). The hypothesis that interaction of TCI with the carboxypeptidases occurs at the same level as their activation segments remains to be tested-e.g., by crystallographic methods or site-directed mutagenesis. In addition, whereas the activation segment inhibits carboxypeptidase activity in a competitive fashion, consistent with its binding to the active site, the inhibition by TCI is hardly reversible and apparently noncompetitive.
TCI gene transcripts were identified in a variety of tissues including brain in which their distribution among regions was somewhat heterogeneous. In all these tissues, a soluble CPAinhibiting activity and a short CPA2 isoform lacking the activation segment were detected (8). TCI, however, being ineffective on this isoform, it seems unlikely that its function is to inhibit its activity in the cell cytoplasm. Nevertheless, the role of TCI might be related to prevention of degradation of cytoplasmic proteins by other proteases that remain to be identified. In addition, post-translational modifications of TCI (e.g., phosphorylation on its three consensus phosphorylation sites) might modify its biological activity. Additional studies are obviously required to circumscribe the functional role of TCI.
